RecruitingNot ApplicableNCT06340178

CT-guided Lung Biopsy Risk Optimization Method

CT-guided Lung Biopsy Risk Optimization Method - Effect of Fluid Application in the Pleural Cavity and the Gravitational Effect of Pleural Pressure


Sponsor

Insel Gruppe AG, University Hospital Bern

Enrollment

198 participants

Start Date

Sep 29, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this randomized controlled study is to evaluate the extent to which injection of a small amount of fluid in the pleural cavity at the biopsy site may reduce the risk of pneumothoraces, in addition to patient positioning to allow biopsy in gravity-dependent areas of the lung.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Fluid application during ct-guided lung biopsy for people with biopsy, needle, pneumothorax, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREFluid application during ct-guided lung biopsy

Injection of a small amount of fluid (max. 20 ml sodium chlorid) in the pleural cavity at the biopsy site


Locations(1)

Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 10

Bern, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06340178


Related Trials